B2i Digital to host Life Sciences Virtual Investor Forum

B2i Digital, Inc. has announced the Life Sciences Virtual Investor Forum, scheduled to take place online on Thursday, September 17, 2026. Hosted by Virtual Investor Conferences, the event features a global lineup of companies presenting in various medical sectors.

Presentations and Q&A sessions will cover topics including oncology, fibrosis, drug delivery, antibiotics, cannabinoid therapeutics, and respiratory imaging. Specific technologies highlighted include photothermal cancer therapy using gold nanorods, precision drug delivery for the blood-brain barrier, and new classes of antibiotics for priority pathogens. Other featured developments include monoclonal antibodies for solid-tumor oncology and FDA-cleared four-dimensional respiratory imaging.

Sessions are designed as 30-minute presentations with audience Q&A, and replays will be made available via the B2i Digital and OTC Markets YouTube channels.